Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Reddy's Laboratories is a leading multinational pharmaceutical company headquartered in Hyderabad, India, dedicated to providing affordable and innovative medicines. The company operates across three main segments: Global Generics, Pharmaceutical Services & Active Ingredients (PSAI), and Proprietary Products. It is a major player in the global generics market, offering a wide range of products in therapeutic areas such as oncology, gastroenterology, and cardiovascular diseases. Dr. Reddy's is increasingly focusing on complex generics, biosimilars, and specialty medicines to drive future growth. The company maintains a significant global footprint with operations in major markets including the United States, India, Russia, and Europe. Through its subsidiary Aurigene Pharmaceutical Services, it also provides comprehensive contract research and manufacturing services to the global biotech industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Pradeep Reddy's Laboratories.